Furthermore, the differences of H3K36me3 cfChIP enrichment in EGFR‐WT and EGFR‐mutant tumours (Fig. 3C) reveal of cfChIP‐seq can be used to study gene expression patterns in NSCLC tumours of different molecular subtypes. This evidence concerns the gene EGFR and non-small cell lung carcinoma.